| pubmed-article:9028356 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9028356 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:9028356 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:9028356 | lifeskim:mentions | umls-concept:C0010803 | lld:lifeskim |
| pubmed-article:9028356 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:9028356 | lifeskim:mentions | umls-concept:C0035363 | lld:lifeskim |
| pubmed-article:9028356 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:9028356 | lifeskim:mentions | umls-concept:C0441704 | lld:lifeskim |
| pubmed-article:9028356 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9028356 | pubmed:dateCreated | 1997-3-4 | lld:pubmed |
| pubmed-article:9028356 | pubmed:abstractText | In a previous study, the authors used a variety of anticytokeratin monoclonal antibodies to show that a large proportion of lung tumors cytologically diagnosed as squamous cell carcinoma contain cells expressing simple epithelial cytokeratins, suggesting that these tumors have their origin in adenocarcinoma. These findings raised the possibility that cytokeratin (CK) typing might have a diagnostic capacity not attainable by standard histopathology. The aim of the current study was to assess the value of CK typing for this purpose by determining the correlation between the diagnosis of lung tumors based on CK typing and the survival rate of the patients. | lld:pubmed |
| pubmed-article:9028356 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9028356 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9028356 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9028356 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9028356 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9028356 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:9028356 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:9028356 | pubmed:author | pubmed-author:GeigerBB | lld:pubmed |
| pubmed-article:9028356 | pubmed:author | pubmed-author:BrudermanII | lld:pubmed |
| pubmed-article:9028356 | pubmed:author | pubmed-author:SiegalAA | lld:pubmed |
| pubmed-article:9028356 | pubmed:author | pubmed-author:CohenRR | lld:pubmed |
| pubmed-article:9028356 | pubmed:author | pubmed-author:HuszarMM | lld:pubmed |
| pubmed-article:9028356 | pubmed:author | pubmed-author:YellinAA | lld:pubmed |
| pubmed-article:9028356 | pubmed:author | pubmed-author:MaromZZ | lld:pubmed |
| pubmed-article:9028356 | pubmed:author | pubmed-author:GubevEE | lld:pubmed |
| pubmed-article:9028356 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9028356 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:9028356 | pubmed:volume | 79 | lld:pubmed |
| pubmed-article:9028356 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9028356 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9028356 | pubmed:pagination | 468-73 | lld:pubmed |
| pubmed-article:9028356 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:meshHeading | pubmed-meshheading:9028356-... | lld:pubmed |
| pubmed-article:9028356 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9028356 | pubmed:articleTitle | The prognostic application of cytokeratin typing of nonsmall cell lung carcinoma. A retrospective study. | lld:pubmed |
| pubmed-article:9028356 | pubmed:affiliation | Department of Pulmonary Medicine, Sapir Medical Center, Meir General Hospital; Sackler School of Medicine, Tel Aviv University, Israel. | lld:pubmed |
| pubmed-article:9028356 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9028356 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
